(Q50548218)

15 March 2018

title

Photodynamic therapy-induced immunosuppression in humans is prevented by reducing the rate of light delivery. (English)

1 reference

15 March 2018

1 reference

Georgia A Frost

1

1 reference

15 March 2018

Gary M Halliday

series ordinal

2

1 reference

15 March 2018

Diona L Damian

series ordinal

3

1 reference

15 March 2018

language of work or name

English

0 references

publication date

20 January 2011

1 reference

15 March 2018

Journal of Investigative Dermatology

published in

1 reference

15 March 2018

volume

131

1 reference

15 March 2018

issue

4

1 reference

15 March 2018

page(s)

962-968

1 reference

15 March 2018

https://scigraph.springernature.com/pub.10.1038/jid.2010.429

exact match

0 references

cites work

Palpation vs pen method for the measurement of skin tuberculin reaction (Mantoux test)

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

The present and future role of photodynamic therapy in cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Photodynamic therapy: update 2006. Part 1: Photochemistry and photobiology

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Measurement of ultraviolet radiation-induced suppression of recall contact and delayed-type hypersensitivity in humans

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl 5-aminolevulinate

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

The Validity and Practicality of Sun-Reactive Skin Types I Through VI

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Oxygen consumption and diffusion effects in photodynamic therapy.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

IL-10 does not play a role in cutaneous Photofrin photodynamic therapy-induced suppression of the contact hypersensitivity response

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Common links among the pathways leading to UV-induced immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

DNA damage and repair in Gorlin syndrome and normal fibroblasts after aminolevulinic acid photodynamic therapy: a comet assay study.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Mitochondria are targets of photodynamic therapy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Human 8-oxoguanine-DNA glycosylase 1 protein and gene are expressed more abundantly in the superficial than basal layer of human epidermis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

UVA radiation is highly mutagenic in cells that are unable to repair 7,8-dihydro-8-oxoguanine in Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Cyclobutane pyrimidine dimer formation is a molecular trigger for solar-simulated ultraviolet radiation-induced suppression of memory immunity in humans

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Topical photodynamic therapy at low fluence rates--theory and practice

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

A time course investigation of the fluorescence induced by topical application of 5-aminolevulinic acid and methyl aminolevulinate on normal human skin.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Topical photodynamic therapy is immunosuppressive in humans

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Guidelines for topical photodynamic therapy: update

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Metronomic PDT and cell death pathways

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Agents that reverse UV-Induced immune suppression and photocarcinogenesis affect DNA repair

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

ATX-S10(Na)-photodynamic therapy is less carcinogenic for mouse skin compared with ultraviolet B irradiation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Erythroplasia of queyrat treated by topical aminolaevulinic acid photodynamic therapy: a cautionary tale

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Development of malignant melanoma after repeated topical photodynamic therapy with 5-aminolevulinic acid at the exposed site

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Topical treatment with OGG1 enzyme affects UVB-induced skin carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Ultraviolet B radiation generated platelet-activating factor receptor agonist formation involves EGF-R-mediated reactive oxygen species

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.429

7 January 2021

Identifiers

DOI

10.1038/JID.2010.429

1 reference

15 March 2018

Dimensions Publication ID

1025283335

0 references

1 reference

15 March 2018